On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Transgene SA's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€707k · 2 projects
- Horizon 2020€0 · 4 projects
- Erasmus+ (ERASMUS+)€0 · 1 project
Projects
7 EU-funded projects, newest first. Transgene SA led 1 of them as coordinator. Each links to the official record.
- LIVE_InnovAssociated partner
Leading International Vaccinology Education for Innovation
Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗
- PERSIST-SEQPartner
Building a reproducible single-cell experimental workflow to capture tumour cell persistence
Horizon 2020 · 2021–2027 · Project on CORDIS ↗
- imSAVARPartner
Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
Horizon 2020 · 2019–2025 · Project on CORDIS ↗
- EUROoCPartner
Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
- TBVAC2020Partner
TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
- IMMUNOCANCoordinator
Toward enhancing activities of European institutions in the FDUSCC-IM cancer research joint institute in China
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
€570ktheir share - O-PTM-BIOMARKERSPartner
Discovery of novel cancer serum biomarkers based on aberrant post translational modifications of O-glycoproteins (O-PTM-Biomarkers) and their application to early detection of cancer
FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗
€137ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Academisch Ziekenhuis LeidenNetherlands · 3 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 2 shared projects
- Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 2 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 2 shared projects
- Kobenhavns UniversitetDenmark · 2 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- Universiteit TwenteNetherlands · 2 shared projects
- Eberhard Karls Universitaet TuebingenGermany · 2 shared projects
- Universite Libre de BruxellesBelgium · 2 shared projects
- Universitat BaselSwitzerland · 2 shared projects
- Universite du LuxembourgLuxembourg · 2 shared projects
- Medizinische Hochschule HannoverGermany · 2 shared projects
- Bundesinstitut Fur Impfstoffe und Biomedizinische ArzneimittelGermany · 2 shared projects
- Universitatsklinikum JenaGermany · 2 shared projects
- Glaxosmithkline Biologicals SABelgium · 2 shared projects
- Institut de Investigacio en Ciencies de la Salut Germans Trias i PujolSpain · 2 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- clinical medicine
- drug discovery
- immunology
- lung cancer
- oncology
- organ on a chip
- proteomics
- toxicology
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
